Outcomes after LA GVHD diagnosis from the Chronic GVHD Consortium (cohort 1)
| Event . | Frequency n (%)* . | Median time to event in months from LA GVHD diagnosis (range) . |
|---|---|---|
| Death | 17 (20) | 5.8 (0.8-23.6) |
| Relapse | 8 (10) | 7.7 (0.7-19.1) |
| Development of chronic GVHD | 23 (28) | 5.4 (0.8-11.3) |
| Recurrence of LA GVHD after complete resolution | 23 (28) | 7.0 (0-13) |
| Successful discontinuation of IST | 20 (24) | 15.7 (4-20) |
| Event . | Frequency n (%)* . | Median time to event in months from LA GVHD diagnosis (range) . |
|---|---|---|
| Death | 17 (20) | 5.8 (0.8-23.6) |
| Relapse | 8 (10) | 7.7 (0.7-19.1) |
| Development of chronic GVHD | 23 (28) | 5.4 (0.8-11.3) |
| Recurrence of LA GVHD after complete resolution | 23 (28) | 7.0 (0-13) |
| Successful discontinuation of IST | 20 (24) | 15.7 (4-20) |
Reported frequencies in this table are raw percentages, not cumulative incidence.